This inventor holds 1 USPTO granted patent. Top assignee: Gongwin Biopharm Holdings Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Kun-Hung Chen: Innovator in Pharmaceutical Compositions
Introduction
Kun-Hung Chen is a notable inventor based in Grand Cayman, KY. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of adenoid cystic carcinoma. His innovative approach has led to the development of a unique pharmaceutical composition that utilizes benzenesulfonamide derivatives.
Latest Patents
Kun-Hung Chen holds 1 patent for his work titled "Pharmaceutical compositions of benzenesulfonamide derivatives for treatment of adenoid cystic carcinoma." This patent provides a method for treating adenoid cystic carcinoma by using a pharmaceutical composition that includes benzenesulfonamide derivatives and pharmaceutically acceptable carriers.
Career Highlights
Chen is associated with Gongwin Biopharm Holdings Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, showcasing his dedication to improving patient outcomes through innovative treatments.
Collaborations
He collaborates with esteemed colleagues such as Chuan-Ching Yang and Nanshan Zhong, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Kun-Hung Chen's contributions to pharmaceutical science exemplify the impact of innovative thinking in medicine. His work not only addresses critical health challenges but also paves the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile